![]() |
市場調查報告書
商品編碼
1551335
2030 年藥品泡殼包裝市場預測:按產品類型、材料、技術、應用、最終用戶和地區進行的全球分析Pharmaceutical Blister Packaging Market Forecasts to 2030 - Global Analysis by Product Type (Carded and Clamshell), Material (Plastic Films, Aluminum, Paper & Paperboard and Biodegradable Materials), Technology, Application, End User and By Geography |
根據Stratistics MRC的數據,2024年全球藥品泡殼包裝市場規模為120.8億美元,預計到2030年將達到184.4億美元,預測期內複合年成長率為7.3%。
藥品泡殼包裝是保護和保存藥品的主要包裝方法。泡殼包裝通常由預先成型的塑膠腔(泡殼)組成,其中包含單劑量的錠劑或膠囊,並用箔片等背襯材料密封。這種包裝方法可確保劑量準確性,防止環境因素影響,並提供防篡改特性,這對於維護藥品的完整性和安全性至關重要。
根據美國國家生物技術資訊中心(NCBI)統計,藥品包裝市場近年來以每年5%以上的速度成長。目前,每年市場規模估計超過200億美元。
對方便、安全包裝的需求不斷成長
製藥業對方便、安全包裝的需求不斷成長,推動了泡殼包裝市場的成長。泡殼包裝具有防篡改功能,可延長保存期限,並可輕鬆分配單一劑量。它還透過以易於查看的方式組織藥物來提高患者的依從性。隨著消費者和醫療保健提供者優先考慮安全性和易用性,製藥公司正在採用泡殼包裝解決方案來滿足這些需求,從而推動市場擴張。
原料高成本
PVC、鋁箔和阻隔膜等原料容易受到價格波動和供應鏈中斷的影響。這些成本通常會轉嫁給消費者,並可能影響藥品的承受能力和可用性。此外,泡殼包裝製造需要專門的設備和工藝,進一步增加了整體成本。這種財務障礙可能會限制採用,特別是小型製藥公司和價格敏感市場。
藥品產量增加
全球藥品產量的增加成為泡殼包裝市場的巨大機會。隨著製藥商增加產量以滿足不斷成長的醫療保健需求,對高效、可靠的包裝解決方案的需求也在增加。泡殼包裝在產品保護、劑量控制和製造效率方面具有優勢。這種趨勢在製藥業快速擴張的新興市場尤其明顯。有機會開發創新且具成本效益的泡殼包裝解決方案,以滿足不斷增加的藥品產量。
替代包裝解決方案
替代包裝解決方案的威脅給藥品泡殼包裝市場帶來了挑戰。瓶、棒和袋包裝的創新提供了具有競爭力的選擇,可能更適合某些藥品或受到某些消費者的青睞。此外,永續包裝趨勢正在推動可取代傳統泡殼包裝的環保替代品的開發。
COVID-19 大流行最初擾亂了供應鏈,但此後提振了對藥品包裝的需求。人們對醫療保健和藥物治療的日益關注增加了藥品的產量並增加了對泡殼包裝的需求。此次疫情也加速了防篡改和注重衛生的包裝解決方案的發展趨勢,使泡殼包裝市場受益。
預計塑膠薄膜產業在預測期內將是最大的
塑膠薄膜在藥品泡殼包裝市場的主導地位是由於其多功能性、成本效益和阻隔性能。塑膠薄膜,特別是 PVC 和 PET,具有優異的防潮性,並且與各種成型和密封工藝相容。由於產品清晰可見,因此也增加了消費者的信心。高阻隔薄膜的創新進一步推動了這一領域的成長,延長了產品的保存期限。隨著製藥公司尋求高效和保護性的包裝解決方案,塑膠薄膜仍然是首選,為市場擴張做出了重大貢獻。
預計雷射切割產業在預測期內複合年成長率最高
藥品泡殼包裝市場雷射切割領域的高複合年成長率歸因於其精度、效率和對複雜設計的適應性。雷射切割技術可實現複雜的形狀和穿孔,提高包裝功能和易用性。與傳統的切割方法相比,它具有減少材料浪費、提高生產速度的優點。對客製化、患者友善包裝設計的需求不斷成長,正在推動雷射切割的採用。該技術能夠滿足嚴格的品質標準並支援創新的包裝解決方案,正在推動市場的快速成長。
由於其強勁的製藥業、嚴格的法規和高額的醫療保健支出,北美在藥品泡殼包裝市場佔據主導地位。該地區對病人安全和藥品完整性的關注與泡殼包裝的優勢是一致的。主要製藥公司和包裝製造商的存在也有助於該領域的持續創新。此外,北美人口老化和慢性病盛行率上升正在增加對處方藥的需求,進一步推動泡殼包裝市場的發展。該地區先進的包裝基礎設施也推動了先進包裝解決方案的採用。
亞太地區藥品泡殼包裝市場的快速成長受到多種因素的推動。製藥業的擴張,尤其是在中國和印度等國家,正在推動對先進包裝解決方案的需求。醫療保健意識的提高、可支配收入的增加和人口的成長正在導致藥物消費的增加。政府改善醫療保健機會的努力也促進了藥品生產。此外,該地區的新興經濟體正在吸引對藥品製造和包裝技術的投資,推動亞太地區的成長。
According to Stratistics MRC, the Global Pharmaceutical Blister Packaging Market is accounted for $12.08 billion in 2024 and is expected to reach $18.44 billion by 2030 growing at a CAGR of 7.3% during the forecast period. Pharmaceutical blister packaging serves as a primary packaging method for safeguarding and preserving medications. It typically consists of a pre-formed plastic cavity (blister) that holds individual doses of pills or capsules, sealed with a backing material such as foil. This packaging method ensures dosage accuracy, protects against environmental factors, and provides tamper-evidence, making it essential for maintaining drug integrity and safety.
According to the National Center for Biotechnology Information (NCBI), the pharmaceutical packaging market has experienced annual growth of at least five percent per year in recent years. The market is now estimated to be worth over $20 billion a year.
Growing demand for convenient and safe packaging
The increasing demand for convenient and safe packaging in the pharmaceutical industry is driving the growth of the blister packaging market. Blister packs offer tamper-evident protection, extend shelf life, and provide easy dispensing of individual doses. They also enhance patient compliance by organizing medications in a clear, visible manner. As consumers and healthcare providers prioritize safety and ease of use, pharmaceutical companies are adopting blister packaging solutions to meet these needs, thereby fueling market expansion.
High cost of raw materials
Materials like PVC, aluminum foil, and barrier films are subject to price fluctuations and supply chain disruptions. These costs are often passed on to consumers, potentially affecting affordability and accessibility of medications. Additionally, the need for specialized equipment and processes for blister pack production further increases overall costs. This financial barrier may limit adoption, particularly among smaller pharmaceutical companies or in price-sensitive markets.
Rising pharmaceutical production
The rising pharmaceutical production worldwide presents a significant opportunity for the blister packaging market. As drug manufacturers increase output to meet growing healthcare demands, the need for efficient and reliable packaging solutions escalates. Blister packaging offers advantages in terms of product protection, dosage control, and manufacturing efficiency. This trend is particularly pronounced in emerging markets where pharmaceutical industries are rapidly expanding. The opportunity lies in developing innovative, cost-effective blister packaging solutions that can keep pace with the growing pharmaceutical production volumes.
Alternative packaging solutions
The threat of alternative packaging solutions poses a challenge to the pharmaceutical blister packaging market. Innovations in bottle packaging, stick packs, and pouches offer competing options that may be more suitable for certain medications or preferred by some consumers. Additionally, sustainable packaging trends are driving the development of eco-friendly alternatives that could potentially replace traditional blister packs.
The COVID-19 pandemic initially disrupted supply chains but subsequently boosted demand for pharmaceutical packaging. Increased focus on healthcare and medication led to higher production of drugs, driving demand for blister packaging. The pandemic also accelerated trends towards tamper-evident and hygiene-focused packaging solutions, benefiting the blister packaging market.
The plastic films segment is expected to be the largest during the forecast period
The plastic films segment's dominance in the pharmaceutical blister packaging market is driven by its versatility, cost-effectiveness, and barrier properties. Plastic films, particularly PVC and PET, offer excellent moisture protection and are compatible with various forming and sealing processes. They allow for clear visibility of the product, enhancing consumer confidence. The segment's growth is further fueled by innovations in high-barrier films that extend product shelf life. As pharmaceutical companies seek efficient, protective packaging solutions, plastic films continue to be the preferred choice, contributing significantly to market expansion.
The laser cutting segment is expected to have the highest CAGR during the forecast period
The laser cutting segment's high CAGR in the pharmaceutical blister packaging market is attributed to its precision, efficiency, and adaptability to complex designs. Laser cutting technology allows for intricate shapes and perforations, enhancing package functionality and ease of use. It offers advantages in terms of reduced material waste and increased production speeds compared to traditional cutting methods. The growing demand for customized, patient-friendly packaging designs is driving the adoption of laser cutting. This technology's ability to meet stringent quality standards and support innovative packaging solutions is fueling its rapid growth in the market.
North America's dominance in the pharmaceutical blister packaging market is driven by its robust pharmaceutical industry, stringent regulations, and high healthcare expenditures. The region's focus on patient safety and drug integrity aligns well with the benefits of blister packaging. The presence of major pharmaceutical companies and packaging manufacturers contributes to continuous innovation in this sector. Additionally, the growing aging population and increasing prevalence of chronic diseases in North America are boosting demand for prescription medications, further driving the blister packaging market. The region's advanced healthcare infrastructure also supports the adoption of sophisticated packaging solutions.
The Asia Pacific region's rapid growth in the pharmaceutical blister packaging market is fueled by several factors. The expanding pharmaceutical industry, particularly in countries like China and India, is driving demand for advanced packaging solutions. Rising healthcare awareness, increasing disposable incomes, and growing populations are contributing to higher medication consumption. Government initiatives to improve healthcare access are also boosting pharmaceutical production. Additionally, the region's emerging economies are attracting investments in pharmaceutical manufacturing and packaging technologies, propelling growth in the Asia Pacific region.
Key players in the market
Some of the key players in Pharmaceutical Blister Packaging market include Amcor plc, WestRock Company, and Constantia Flexibles, alongside other significant contributors like Klockner Pentaplast Group, Honeywell International Inc., Bemis Company Inc., ACG Pharmapack Pvt. Ltd., Sonoco Products Company, Bilcare Research Inc., Winpak Ltd., Uflex Ltd., RENOLIT SE, Tekni-Plex, Inc., Carcano Antonio S.p.A., Caprihans India Limited, The Dow Chemical Company, DuPont de Nemours, Inc., and PCI Pharma Services.
In July 2022, Honeywell's Aclar range of barrier film blisters received technical recyclability recognition from TerraCycle, marking a milestone in pharmaceutical packaging recyclability.
In April 2021, Amcor announced customer trials for AmSky, the world's first recyclable polyethylene-based thermoform blister packaging. It's designed to meet stringent pharmaceutical packaging requirements while being recyclable.
In February 2020, Sonoco's Alloyd division introduced EnviroSense PaperBlister, an all-paper retail blister package as an environmentally friendly alternative to thermoformed plastic blister packages.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.